期刊文献+
共找到1篇文章
< 1 >
每页显示 20 50 100
Recent advances in access to overcome cancer drug resistance by nanocarrier drug delivery system 被引量:1
1
作者 Xiangyu Sun Ping Zhao +2 位作者 jierou lin Kun Chen Jianliang Shen 《Cancer Drug Resistance》 2023年第2期390-415,共26页
Cancer is currently one of the most intractable diseases causing human death.Although the prognosis of tumor patients has been improved to a certain extent through various modern treatment methods,multidrug resistance... Cancer is currently one of the most intractable diseases causing human death.Although the prognosis of tumor patients has been improved to a certain extent through various modern treatment methods,multidrug resistance(MDR)of tumor cells is still a major problem leading to clinical treatment failure.Chemotherapy resistance refers to the resistance of tumor cells and/or tissues to a drug,usually inherent or developed during treatment.Therefore,an urgent need to research the ideal drug delivery system to overcome the shortcoming of traditional chemotherapy.The rapid development of nanotechnology has brought us new enlightenments to solve this problem.The novel nanocarrier provides a considerably effective treatment to overcome the limitations of chemotherapy or other drugs resulting from systemic side effects such as resistance,high toxicity,lack of targeting,and off-target.Herein,we introduce several tumor MDR mechanisms and discuss novel nanoparticle technology applied to surmount cancer drug resistance.Nanomaterials contain liposomes,polymer conjugates,micelles,dendrimers,carbon-based,metal nanoparticles,and nucleotides which can be used to deliver chemotherapeutic drugs,photosensitizers,and small interfering RNA(siRNA).This review aims to elucidate the advantages of nanomedicine in overcoming cancer drug resistance and discuss the latest developments. 展开更多
关键词 Cancer NANOMEDICINE NANOMATERIALS drug delivery multidrug resistance
原文传递
上一页 1 下一页 到第
使用帮助 返回顶部